Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1344706
rs1344706
0.010 GeneticVariation BEFREE Together, these results indicated that IQ may modulate the role of rs1344706 in the etiology of both schizophrenia and its cognitive impairments, and pointed to the necessity of considering general cognitive function as indexed by IQ in the future studies of genetic bases of schizophrenia. 22373944

2012

dbSNP: rs17070145
rs17070145
0.020 GeneticVariation BEFREE In comparison to APOE ε4-ve individuals carrying the rs17070145-T allele, significantly faster rates of cognitive decline (global, p = 0.006; verbal episodic memory, p = 0.004), and hippocampal atrophy (p = 0.04) were observed in individuals who were APOE ε4 + ve and did not carry the rs17070145-T allele. 29391469

2018

dbSNP: rs17070145
rs17070145
0.020 GeneticVariation BEFREE No increased risk of any type of late development, and cognitive impairment was associated with rs6439886 or rs17070145. 21643791

2012

dbSNP: rs80338903
rs80338903
T 0.700 CausalMutation CLINVAR

dbSNP: rs7840202
rs7840202
C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment. 22833209

2011

dbSNP: rs387906709
rs387906709
0.010 GeneticVariation BEFREE Overexpression of Ubqln2 with a pathogenic mutation (P497H substitution) caused cognitive deficits and neuronal loss in transgenic rats at the age of 130 days. 25388785

2015

dbSNP: rs781587642
rs781587642
0.010 GeneticVariation BEFREE In TUBA4A, we detected a novel frameshift mutation (p.Arg64Glyfs*90) leading to a truncated protein in 1 FTD patient (1/459 of 0.22%) with family history of Parkinson's disease and cognitive impairment, and a novel missense mutation (p.Thr381Met) in 2 sibs with familial ALS and memory problems (1 index patient/429, 0.23%) in whom we previously identified a pathogenic Chromosome 9 open reading frame 72 repeat expansion mutation. 28069311

2017

dbSNP: rs111231532
rs111231532
C 0.700 GeneticVariation GWASCAT Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level. 26252872

2015

dbSNP: rs1569151872
rs1569151872
AA 0.700 GeneticVariation CLINVAR Mutations in TSPEAR, Encoding a Regulator of Notch Signaling, Affect Tooth and Hair Follicle Morphogenesis. 27736875

2016

dbSNP: rs139455627
rs139455627
A 0.700 GeneticVariation CLINVAR Mutations in TSPEAR, Encoding a Regulator of Notch Signaling, Affect Tooth and Hair Follicle Morphogenesis. 27736875

2016

dbSNP: rs145959269
rs145959269
G 0.700 GeneticVariation GWASCAT Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level. 26252872

2015

dbSNP: rs147368169
rs147368169
A 0.700 GeneticVariation GWASCAT Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level. 26252872

2015

dbSNP: rs200956582
rs200956582
0.700 GeneticVariation GWASCAT Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level. 26252872

2015

dbSNP: rs75932628
rs75932628
0.010 GeneticVariation BEFREE We also found that the TREM2 R47H gene variant was associated with changes in cognitive decline in the large cohort of HD patients, whereas 2 of 3 TLR4 single nucleotide polymorphisms assessed were associated with changes in motor progression in this same group. 31724242

2020

dbSNP: rs6910730
rs6910730
0.010 GeneticVariation BEFREE We provide evidence that an intronic variant, rs6910730(G) , in TREM1, is associated with an increased burden of neuritic plaques (p = 3.7 × 10(-4) ), diffuse plaques (p = 4.1 × 10(-3) ), and Aβ density (p = 2.6 × 10(-3) ) as well as an increased rate of cognitive decline (p = 5.3 × 10(-3) ). 25545807

2015

dbSNP: rs121912651
rs121912651
A 0.700 CausalMutation CLINVAR

dbSNP: rs10524523
rs10524523
0.020 GeneticVariation BEFREE To interrogate a poly-T variant (rs10524523, '523) in <i>TOMM40</i>, a gene adjacent to the <i>APOE</i> gene on chromosome 19, in older persons with <i>APOE</i> ε3/3 homozygosity for association with cognitive decline, the clinical hallmark of Alzheimer disease (AD). 28108637

2017

dbSNP: rs10524523
rs10524523
0.020 GeneticVariation BEFREE The very long (VL) poly-T variant at rs10524523 ("523") of the TOMM40 gene may hasten the onset of late-onset Alzheimer's disease (LOAD) and induce more profound cognitive impairment compared with the short (S) poly-T variant. 25862420

2015

dbSNP: rs115881343
rs115881343
0.010 GeneticVariation BEFREE We found 2 independent associations among European-Americans in the 19q13.32 region: rs769449 (APOE intron; p = 3.1 × 10(-20)) and rs115881343 (TOMM40 intron; p = 6.6 × 10(-11)). rs769449 was also associated with cognitive decline among African-Americans (p = 0.005), but rs115881343 was not. 24468470

2014

dbSNP: rs157582
rs157582
0.010 GeneticVariation BEFREE The minor allele of rs4420638 (G) and the minor allele of rs157582 (T) showed associations with lower Mini-mental State Examination score, higher Alzheimer Disease Assessment Scale-cognitive subscale 11 score and smaller entorhinal volume using both baseline and longitudinal measurements, as well as with accelerated cognitive decline. 31760383

2019

dbSNP: rs2075650
rs2075650
0.010 GeneticVariation BEFREE Our prevalent case study comparing prevalent AD cases (n = 428) with participants with no cognitive impairment (n = 524) revealed a significant association of rs6656401 and rs3818361 (CR1), rs2075650 (TOMM40), rs7561528 (BIN1), and rs3865444 (CD33) with late-onset AD that were robust to adjustment with age and apolipoprotein E ε4 genotype. 24176626

2014

dbSNP: rs1554948
rs1554948
0.010 GeneticVariation BEFREE In a multicenter case-control association study, we studied the SNPs rs11136000 (clusterin, CLU), rs541458 (phosphatidylinositol binding clatrin assembly protein, PICALM), and rs1554948 (transcription factor A, and tyrosine kinase, non-receptor, 1, TNK1) according to the three age groups 50-65 years (group 1), 66-80 years (group 2), and 80+ years (group 3) in 569 older subjects without cognitive impairment (NoCI) and 520 Alzheimer's disease (AD) patients. 28631188

2018

dbSNP: rs1800629
rs1800629
TNF
0.010 GeneticVariation BEFREE Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients. 27701469

2016

dbSNP: rs117605016
rs117605016
C 0.700 GeneticVariation GWASCAT Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level. 26252872

2015

dbSNP: rs1558027212
rs1558027212
G 0.700 GeneticVariation CLINVAR